Innovator Etfs Trust Etf Current Ratio
INOV Etf | USD 28.88 0.06 0.21% |
Innovator ETFs Trust fundamentals help investors to digest information that contributes to Innovator ETFs' financial success or failures. It also enables traders to predict the movement of Innovator Etf. The fundamental analysis module provides a way to measure Innovator ETFs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovator ETFs etf.
Innovator |
Innovator ETFs Trust ETF Current Ratio Analysis
Innovator ETFs' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Innovator ETFs Current Ratio | 2.17 X |
Most of Innovator ETFs' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovator ETFs Trust is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
In accordance with the recently published financial statements, Innovator ETFs Trust has a Current Ratio of 2.17 times. This is much higher than that of the Health Care Technology family and significantly higher than that of the Defined Outcome category. The current ratio for all United States etfs is notably lower than that of the firm.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Innovator Fundamentals
Return On Equity | 0.0716 | |||
Return On Asset | 0.0331 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.14 % | |||
Current Valuation | 7.22 B | |||
Shares Outstanding | 77.17 M | |||
Shares Owned By Insiders | 3.99 % | |||
Shares Owned By Institutions | 75.85 % | |||
Number Of Shares Shorted | 4.45 M | |||
Price To Earning | 188.89 X | |||
Price To Book | 8.31 X | |||
Price To Sales | 8.25 X | |||
Revenue | 667.52 M | |||
Gross Profit | 499.7 M | |||
EBITDA | 186.56 M | |||
Net Income | 22.58 M | |||
Cash And Equivalents | 128.63 M | |||
Cash Per Share | 0.82 X | |||
Total Debt | 897.3 M | |||
Debt To Equity | 1.39 % | |||
Current Ratio | 2.17 X | |||
Book Value Per Share | 4.91 X | |||
Cash Flow From Operations | 146.36 M | |||
Short Ratio | 6.78 X | |||
Earnings Per Share | 0.34 X | |||
Price To Earnings To Growth | 5.24 X | |||
Target Price | 41.8 | |||
Number Of Employees | 31 | |||
Beta | 0.53 | |||
Market Capitalization | 6.37 B | |||
Total Asset | 1.97 B | |||
Retained Earnings | 300.89 M | |||
Working Capital | 158.8 M | |||
Current Asset | 844.01 M | |||
Current Liabilities | 67.53 M | |||
One Year Return | 10.50 % | |||
Net Asset | 1.97 B |
About Innovator ETFs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovator ETFs Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovator ETFs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovator ETFs Trust based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Innovator ETFs Piotroski F Score and Innovator ETFs Altman Z Score analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
The market value of Innovator ETFs Trust is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator ETFs' value that differs from its market value or its book value, called intrinsic value, which is Innovator ETFs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator ETFs' market value can be influenced by many factors that don't directly affect Innovator ETFs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator ETFs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator ETFs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator ETFs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.